Literature DB >> 9989336

Indinavir-fluconazole interaction.

S E Bellibas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9989336      PMCID: PMC89099     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study.

Authors:  P Lorenzi; S Yerly; K Abderrakim; M Fathi; O T Rutschmann; J von Overbeck; D Leduc; L Perrin; B Hirschel
Journal:  AIDS       Date:  1997-10       Impact factor: 4.177

Review 2.  Update: clinically significant cytochrome P-450 drug interactions.

Authors:  E L Michalets
Journal:  Pharmacotherapy       Date:  1998 Jan-Feb       Impact factor: 4.705

Review 3.  Resistance to anti-human immunodeficiency virus therapeutic agents.

Authors:  E A Emini
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

4.  Effect of fluconazole on indinavir pharmacokinetics in human immunodeficiency virus-infected patients.

Authors:  S De Wit; M Debier; M De Smet; J McCrea; J Stone; A Carides; C Matthews; P Deutsch; N Clumeck
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of fluconazole.

Authors:  D Debruyne; J P Ryckelynck
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

  5 in total
  1 in total

Review 1.  MDR- and CYP3A4-mediated drug-drug interactions.

Authors:  Dhananjay Pal; Ashim K Mitra
Journal:  J Neuroimmune Pharmacol       Date:  2006-08-02       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.